Good points Hodgie. Efti’s method of action is unique, it’s not...

Good points Hodgie.
Efti’s method of action is unique, it’s not a checkpoint inhibitor which is Imugene’s line of attack and many other Lag3 products in trial including BMS’s phase3 trial.
Efti also appears to be completely safe with no increase in toxicity in conjunction with other treatments and appears to roughly double the efficacy of existing treatments

Final results from AIPAC are big but they need to be considered in the light of TACTI 002 great results and fast track designation when arriving at a valuation. Great results will continue flowing from Tacti-002

Critical 12 month period ahead